We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Risk factors and the resistance mechanisms involved in Pseudomonas aeruginosa mutation in critically ill patients.
- Authors
Druge, Stéphanie; Ruiz, Stéphanie; Vardon-Bounes, Fanny; Grare, Marion; Labaste, François; Seguin, Thierry; Fourcade, Olivier; Minville, Vincent; Conil, Jean-Marie; Georges, Bernard
- Abstract
Background: The objective of this study was to determine the main risk factors of Pseudomonas aeruginosa mutation as well as the mechanisms of acquired resistance. Methods: We conducted a 2-year prospective study in patients who were carriers of a Pseudomonas aeruginosa strain and who had been admitted to a medical/surgical ICU. Results: Of the 153 patients who were included, 34 had a mutation in their strain. In a multivariate analysis, a duration of ventilation > 24 days was a risk factor for mutation (risk ratio 4.29; CI 95% 1.94–9.49) while initial resistance was a protective factor (RR 0.36; CI 95% 0.18–0.71). In a univariate analysis, exposure of P. aeruginosa to ceftazidime was associated with an over-production of AmpC cephalosporinase and exposure to meropenem was associated with impermeability. A segmentation method based on the duration of ventilation (> 24 days), initial resistance, and exposure of strains to ceftazidime made it possible to predict at 83% the occurrence of mutation. Conclusion: The duration of ventilation and the presence of resistance as soon as P. aeruginosa is identified are predictive factors of mutation in ICU patients.
- Subjects
PSEUDOMONAS aeruginosa; CRITICALLY ill; DISEASE risk factors; BETA lactamases; CEFTAZIDIME
- Publication
Journal of Intensive Care, 2019, Vol 7, Issue 1, pN.PAG
- ISSN
2052-0492
- Publication type
Article
- DOI
10.1186/s40560-019-0390-4